Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Starkhammar

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Effect of portal blood flow and intra-arterially injected starch microspheres on the passage of a labelled tracer through the liver. An experimental study in pigsH Starkhammar, L Håkansson, R Sjödahl, et al.
Biomedical Instrumentation & Technology|March 1, 1996
Central venous catheter placement using electromagnetic position sensing: a clinical evaluationH Starkhammar, M Bengtsson, D A Kay, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2014
Variation at presentation among colon cancer patients with metastases: a population-based studyP A Heedman, E Canslätt, G Henriks, et al.
European Journal of Haematology|July 1, 1997
Infradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience. The Swedish Lymphoma Study GroupK M Kälkner, G Enblad, A Gustavsson, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
A new injection portal for brachially inserted central venous catheter. A multicenter studyH Starkhammar, M Bengtsson, T B Gain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2008
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracilC Qvortrup, M Yilmaz, D Ogreid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilP Pfeiffer, H Sørbye, H Ehrsson, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerD Cunningham, S Pyrhönen, R D James, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Effect of portal blood flow and intra-arterially injected starch microspheres on the passage of a labelled tracer through the liver. An experimental study in pigsH Starkhammar, L Håkansson, R Sjödahl, et al.
Biomedical Instrumentation & Technology|March 1, 1996
Central venous catheter placement using electromagnetic position sensing: a clinical evaluationH Starkhammar, M Bengtsson, D A Kay, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 17, 2014
Variation at presentation among colon cancer patients with metastases: a population-based studyP A Heedman, E Canslätt, G Henriks, et al.
European Journal of Haematology|July 1, 1997
Infradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience. The Swedish Lymphoma Study GroupK M Kälkner, G Enblad, A Gustavsson, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
A new injection portal for brachially inserted central venous catheter. A multicenter studyH Starkhammar, M Bengtsson, T B Gain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2008
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracilC Qvortrup, M Yilmaz, D Ogreid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancerB Glimelius, H Sørbye, L Balteskard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilP Pfeiffer, H Sørbye, H Ehrsson, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerD Cunningham, S Pyrhönen, R D James, et al.
Pageof 3